Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs top healthcare stocks. On March 10, Johnson & Johnson (NYSE:JNJ) announced the submission of a Type II variation application to the European ...

The approval was supported by data from the ongoing Phase III MajesTEC-3 study.

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

After Maine's Total Weather chief meteorologist Roger Griswold shared his multiple myeloma diagnosis, we're looking at what ...

For patients facing a multiple myeloma diagnosis, the journey is often defined by a search for the next line of defense. For survivor Julie Cohen, that search led her to the front lines of medical ...

During a live event, Marc J. Braunstein, MD, PhD, and participants discussed maintenance lenalidomide and daratumumab as well as the clinical potential of MRD in multiple myeloma.

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and ...

SHREVEPORT, La. - March is Multiple Myeloma Awareness Month, bringing attention to a disease that doctors say many people know little about.

It is to “transform an event into a driver of hope” that David Gagné has set himself the goal of cycling across Quebec next June to raise awareness of multiple myeloma, an incurable blood cancer that ...

Bonnie was exhausted. It was late 2001, and she’d been working a high-pressure job – barely getting any sleep. “I’d wake up tired, I’d go to bed tired,” she says. She didn’t think much of it, but she ...